The placenta is a highly differentiated organ essential for embryonic growth and development. In order to search for key molecules that are associated with mouse placental lactogen II (mPL-II) gene expression, we applied mouse cDNA microarray analysis to RNAs extracted from placentae on days 10, 12, 14, 16 and 18 of pregnancy. Changes in gene expression were categorized between days 10 and 12, 12 and 14, 14 and 16 and 16 and 18 of pregnancy. After microarray analysis, which had a minimum detectable fold change for differential expression of 2, we selected 10 genes, Apoa2, Apoc2, Ceacam14, Creg1, Fmo1, Igf2, Slc2a1, Spink3, Spi1-1 and Tpbpa, exhibiting a expression pattern similar to the mPL-II gene. Furthermore, we performed real-time PCR analysis and in situ hybridization (ISH) to find correlative expression genes for the mPL-II gene. From these results, we identified a resemblance in gene expression between mPL-II and Igf2 and selected these genes for performance of double-fluorescence immunohistochemical staining. We colocalized these proteins in labyrinthine trophoblast cells. These results strongly suggest that the expression of mPL-II and Igf2 is highly related to placental development in mice. This large-scale identification of genes regulated during placentogenesis assists in further elucidation of the molecular basis of extraembryonic development and function.
he placenta is a biologically specific organ in mammals. It is mainly developed from extraembryonic tissue and maternal uterine parietal cells [1] . In terms of placental structure, the basal zone has mainly endocrine functions and secretes many substances, whereas the function of the labyrinth zone is transportation of nutrition and waste and exchange of oxygen and carbon dioxide. Thus, the placenta is the site of transfer between the mother and fetus and serves as a barrier that prevents migration of cells between these two compartments.
The placenta is also an autocrine, paracrine, and endocrine organ that synthesizes a broad range of steroids and peptide hormones that regulate development of the fetoplacental unit and alter maternal physiology to support this process. Among the various regulatory signals secreted by the uterus and placenta, these are a prominent family of proteins related to pituitary prolactin that are known as the prolactin family [2] [3] [4] . At least 26 different members of the prolactin (PRL) family of genes have been identified, including placental lactogen (PL), PRL-like proteins (PLPs), PRLrelated proteins (PRPs), proliferin (PLF), and PLF-Accepted for publication: September 15, 2006 Published online: October 24, 2006 Correspondence: M. Ishida (e-mail: michi@isc.meiji.ac.jp) related protein (PLF-RP) [5] . PRL family ligands are expressed in cell-and temporal-specific patterns in the anterior pituitary and uteroplacental compartment [4, [6] [7] [8] . An overall characteristic of PRL families is their association with pregnancy and regulatory mechanisms controlling viviparity. Yet, numerous genes have been identified as day s p e c i f i c , a n d t h e m e c h a n i s m s o f p l a c e n t a development and maintenance are still largely unknown.
In a recent study, the members of the human prolactin/growth hormone (PRL/GH) family displayed an angiogenic function in vascular formation, whereas their respective 16-kDa Nterminal fragments displayed the opposite effect, an antiangiogenic function [9] . The 16-kDa fragment of PRL was cleaved from intact 23-kDa PRL. Cathepsin D has been demonstrated to cleave PRL to give the corresponding fragments of 16-kDa PRL [10] . When remodeling of the maternal uterine vasculature and growth of fetal vessels into the p l a c e n t a t a k e s p l a c e a f t e r i m p l a n t a t i o n , angiogenesis is essential for development of the placenta. We previously speculated that the placentally expressed cathepsin (PECs) family [11] would cleave intact mPL-II in a manner similar to cathepsin D cleavage of PRL. Based on this hypothesis, our previous work focused on the r e l a t i o n s h i p b e t w e e n P L a n d P E C s . W e demonstrated that cathepsin M, Q, and R in the gene expressions of PECs exhibited a similar pattern to mPL-II by cDNA subtraction analysis [12] , and cathepsin Q and R mRNAs were colocalized in mPL-II immunoreactive cells in the labyrinth zone of the placenta.
In the present study, we applied mouse cDNA microarray analysis for mid-to late-stage mouse placentae in order to search for the key factors involved in mPL-II and PECs gene expression. This approach identified both the expression and localization of a large number of genes in extraembryonic tissues and thus contributes largely to the understanding of molecular basis of placental development and function especially in terms of angiogenetic factors.
Materials and Methods

Animals and total RNA preparation
The animal management and experimental procedures in this study were performed according to the guidelines for animal experimentation established at Meiji University. In this study, ICR mice were used for tissue collection and total RNA preparation. Total RNA was isolated from placentae on days 10, 12, 14, 16 and 18 of pregnancy (P10, P12, P14, P16, P18) (n=3 per day for real-time RT-PCR) using on Isogen RNA extraction kit (Nippon Gene, Tokyo, Japan). RNA samples were quantified by spectrophotometry at 260 nm and then separated with an Agilent 2100 Bioanalyzer (Agilent Technologies, Foster City, CA, USA) to determine their integrity.
cDNA microarray analyses
Cyanin-3 (Cy3) and cyanin-5 (Cy5)-labeled probes prepared using total RNA extracted from mouse placentae were used for cDNA microarray analyses. Microarray hybridization was performed using a Mouse cDNA Microarray Kit G4104A (8500 genes; Agilent Technologies). Primary data were examined using Feature Extraction Software (Agilent Technologies) and the Rossetta Luminator System (Rossetta Biosoftware, WA, Seattle, USA).
Real-time PCR
First strand cDNA synthesis was performed with 2 µg of total RNA from P10, P12, P14, P16 and P18 placentae using Superscript II RNase H-Reverse Transcriptase (RT; Invitrogen, Carlsbad, CA, USA) and random hexamer primers according to the manufacturer's protocol. Real-time PCR was performed using an ABI Prism 7700 Sequence Detector (Applied Biosystems, Foster City, CA, USA). SYBR Green was used to detect the PCR products of selected genes including GAPDH. The melting point, optimal conditions, and specificity of the reaction were first determined using standard procedures. Quantitative PCR was carried out in a 96-well plate with 100 nM of forward and reverse primers and the SYBR Green working solution using a custom PCR master mix under the following conditions: 50 C for 30 min; 95 C for 15 min; 94 C for 5 min; and 40 cycles at 94 C for 1 min, 55 C for 30 sec and 72 C for 1 min. Every assay included to test the respective cDNA samples, 10fold serial dilutions of the standard qualification, and controls (no template). Each transcript quantification was calculated as the value relative to GAPDH. Values were calculated as mean ± SE for n=3 separate samples per day and were expressed in terms of arbitrary units per ng total RNA in the reverse transcription reaction. Statistical analyses were performed using Sequence Detection System with the RQ software (Applied Biosystems).
Tissue preparation
Placental tissues were removed immediately after sacrifice of mice for in situ hybridization (ISH) and immunohistochemistry, fixed in 4% paraformaldehyde at 4 C overnight, and embedded in paraffin. Sections (6 µm thick) were cut on a microtome and mounted onto silane-coated slides. Serial sections were prepared for ISH to compare the expression sites of the two selected genes.
In situ hybridization
For ISH, probes for each gene were prepared from RT-PCR products. Digoxigenin-dUTPlabeled RNA probes were prepared with a DIG RNA Labeling Kit (Roche Applied Science, M a n n h e i m , G e r m a n y ) a c c o r d i n g t o t h e manufacturer's instructions. ISH was conducted using the standard procedure [13] . Signals were detected using an anti-digoxigenin-alkaline phosphatase-conjugated antibody (Roche Applied Science). The color reaction was developed by incubation with NBT/BCIP. Sense DIG-labeled cRNA probes were used as negative controls.
Immunohistochemistry
Double-fluorescence immunohistochemistry was performed to colocalize the mPL-II and Igf2 expressions in the mouse placenta. The sections were autoclaved in 10 mM sodium citrate (pH 6) and blocked in 10% (v/v) bovine normal serum in PBS for 1 h. After rinsing in PBS, the sections were incubated with rabbit anti-mouse PL-II serum (the generous gift of Dr. Frank Talamantes; 1:5,000 in blocking buffer) and goat antimouse Igf2 antibody (R&D Systems, Minneapolis, MN, USA; 1:20 in blocking buffer) at 4 C overnight. After rinsing with PBS, the sections were incubated with rhodamine-conjugated goat anti-rabbit IgG (1:500 in blocking buffer) and FITC rabbit anti-goat IgG 
Results
Assembly of the developmental mouse placenta cDNA microarray
We applied mouse cDNA microarray analysis to compare placentae on P10 and P12, P12 and P14, P14 and P16, and P16 and P18 of pregnancy. Each R N A s a m p l e w a s u s e d t o s y n t h e s i z e t w o complementary DNA targets, one labeled with Cy3 and another labeled with Cy5. Hybridizations were conducted as a dye-swapped pair on the two arrays of a single slide with one replicate. For example, one array reacted with Cy3-labelled P10:Cy5-labelled P12 and another array reacted with Cy5-labelled P10:Cy3-labelled P12. The fluorescence intensities of the scanned images were quantified and normalized. Some of the 8,500 genes were significantly regulated across the day of samples; that is, there was at least a 2-fold difference.
The intensities of the Cy3 and Cy5 signals d e r i v ed f r om e a ch d a y o f p l a c en t a e w er e compared, and log2-transformed Cy3/Cy5 expression ratios of the data set were then subjected to two forms of mathematical clustering analyses using hierarchical tree and K-means algorithms (data not shown). Based on analysis with Feature Extraction Software and the Rosetta Luminator System, 10 gene expressions were found that were similar in expression pattern to that of the mPL-II gene. These included apolipoprotein A-II (Apoa2); apolipoprotein C-II (Apoc2); CEA-related cell adhesion molecule 14 (Ceacam14); cellular repressor of E1A-stimulated genes (Creg1); flavincontaining monooxygenase 1 (Fmo1); insulin-like growth factor 2 (Igf2); solute carrier family 2 (Slc2a1); serine protease inhibitor, Kazal type 3 (Spink3); serine protease inhibitor 1-1 (Spi1-1); and trophoblast specific protein alpha (Tpbpa) (data not shown). The cathepsin B, D and M expression patterns were also similar to the mPL-II gene expression. However, the cathepsin data was not included in this study because their expressions and localizations were shown in our previous study [12] . Cathepsin Q and R were also not included in this array.
Comparison between mPL-II gene and each selected gene expression
Real-time PCR analysis of correlative gene expression was performed to confirm the data obtained from the microarray analysis. Consistent with the microarray analysis, the expression patterns of Ceacam14, Fmo1, Igf2, Slc2a1 and Tpbpa were similar to that of mPL-II. They gradually increased until P16 and then decreased at P18 (Fig. 1) .
From the results of ISH, we discovered that the Ceacam 14 and Tpbpa mRNA were only observed in the basal zone of the placenta, whereas the other mRNAs were observed in both the basal and labyrinth zone of the placenta (Fig. 2) . It has been shown in morphological observations that mPL-II is secreted from the trophoblast cells in the labyrinth zone and giant trophoblast cells in the junctional zone of the placenta [4] . In order to compare the expression sites of mRNAs between the selected genes and the mPL-II gene, serial sections were used for ISH. As a result, the hybridization signals of the Creg, Spink3, Spi1-1 and Igf2 genes were observed in similar cells as for mPL-II in the labyrinth zone of the placenta on day 16 of pregnancy (Fig. 2) . No signals were observed in any sections with a sense probe (data not shown). The real-time PCR and ISH results are summarized in Table 1 .
Colocalization of mPL-II and Igf2
Based on the results obtained by real-time PCR and ISH, Igf2 was selected for further analysis because it was most similar to the mPL-II pattern. It was also thought that Igf2 might have an influence on mPL-II gene expression and that it might be associated with the fetal growth and differentiation of the mouse. To clarify the cell types expressing mPL-II and Igf2 in the labyrinth zone of the placenta, we performed doublefluorescence immunohistochemistry. The cells immunoreactive for mPL-II antibody were the same as those immunoreactive for Igf2 in the labyrinth zone of the placenta on day 16 of pregnancy ( Fig. 3) . As mPL-II was secreted from the trophoblast cells in the labyrinth zone and giant trophoblast cells in the junctional zone of the placenta, the cells expressing Igf2 in the labyrinth zone were also trophoblast cells based on the results of double-fluorescence immunohisto-chemistry. No positive immunoreactions were observed in sections incubated with blocking buffer.
Discussion
In our previous work, we studied specific gene expression related to mPL synthesis using cDNA subtraction analysis that specifically identified cathepsin family genes [12] . In the present study, we employed cDNA microarray analysis, which was expected to be more sensitive than cDNA subtraction analysis, for the detection of specific genes related to mPL gene expression, including angiogenetic genes. Based on the hierarchical tree and K-means algorithms, we selected 10 genes that had expression patterns that were similar to that of the mPL-II gene. Finally, real-time PCR analysis found correlative expression for 5 genes to the mPL-II gene. ISH analysis revealed that the localizations of 4 of the genes were similar to mPL-II. Furthermore, we identified colocalization of mPL-II and Igf2 in the labyrinthine trophoblast cells. Table 1 shows the respective gene expression periods and localizations in the placenta along with a comparison to mPL-II. Although most of these gene expressions have already been identified in the placenta, the expression periods and regions of these genes were unclear until the present study. Therefore, these results might be useful in elucidating the function of PL and its associated genes in the placenta.
The functions of these previously characterized genes are described in Table 1 . Both Tpbpa and Ceacam14 are expressed in the placenta and are known as markers for trophoblast cells in mice, but the functions of these genes have not been elucidated.
Taking the functions of these into consideration, with the exception of Tpbpa and Ceacam14, we believe that there are potential roles for each of these genes in the placenta. Slc2a1 and Fmo1 may participate in the interaction between mothers and embryos. Spink3, Spi1-1, Apoc2 and Apoa2 could be considered factors involved in the invasion of trophoblast cells into the decidua. Spink3 and Spi1-1 are serine protease inhibitors whose function in the placenta is unknown. Apolipoproteins are necessary for transport of hydrophobic lipid in blood as lipoprotein.
Igf2 is a potential target for glucocorticoid actions on placental development. There is evidence that glucocorticoids regulate Igf2 expression in a variety of cell types and tissues in both the in vitro and in vivo models [14, 15] , and Igf2 is viewed as a key autocrine/paracrine placental growth factor [16] .
In the mouse, Igf2 null mutations lead to significant intrauterine growth retardation of both the fetus and placenta [17] . The rodent placenta possesses all components necessary for the Igf2 signaling pathway [18, 19] . Placental growth restriction following dexamethasone treatment is associated with dysregulated placental PRL family gene expression and down-regulation of the Igf2/Akt signaling pathway leading to increases in the induction of placental apoptosis [20] . Several investigators have suggested that there might be a possible link between PL and Igf1 and Igf2. Tenday rat embryos were cultured in serum-depleted medium in the presence and absence of human (h) PL with the addition of Igf antisera. Addition of hPL to the depleted serum significantly improved embryonic growth and development, suggesting that the developing embryo may utilize hPL [21] . In this study, colocalization of mPL-II and Igf2 was observed in trophoblast cells in the labyrinth zone and giant trophoblast cells in the junctional zone of the placenta. Igf2 and Creg1 can be considered to be key factors that participate in placental and e m b r y o n i c g r o w t h . C r e g 1 i s a s e c r e t e d g l y c o p r o t e i n t h a t a n t a g o n i z e s c e l l u l a r transformation by E1A and Ras. It binds directly to the Igf2 receptor (Igf2R) dependent on Creg1 glycosylation [22] . Creg1 inhibits cell growth dependent on Igf2R, and this suggests that i n t e r a c t i o n s b e t w e e n C r e g 1 a n d a w e l lcharacterized placental growth factor may contribute to regulation of proliferation and differentiation in multiple lineages. Furthermore, Igf2 has been found to interact with cathepsin, which has been identified as a specific gene related to mPL-II synthesis, using the subtracted cDNA libraries in our previous work [12] . It has also been reported that lysosomal enzyme cathepsin D and Igf2, which share a common Igf2 / mannose-6-phosphate (M6P) transmembrane receptor, are synthesized and secreted by breast cancer cells. Igf2 promotes cathepsin D secretion in breast cancer cells that potentially regulates cell proliferation and/or invasion [23] . On the other hand, Igf2 inhibites the cellular uptake of cathepsin D by inhibiting its binding to the Igf2/ M6P receptor. We previously suggested that the placentally expressed cathepsin family could cleave intact mPL-II in a manner similar to that of cathepsin D cleavage of PRL [12] . PRL/GH family placental hormones appear to play a role in the regulation of reorganization and growth of maternal and fetal blood vessels in the placenta [4, 24] . Therefore, PL-II may be cleaved from 23-kDa forms by PECs and this might be induced by Igf2, thereby affecting placental vascular formation.
